INVASIVE PULMONARY ASPERGILLOSIS DUE TO A MULTI-AZOLE RESISTANT ASPERGILLUS FUMIGATUS

REFERENCES

• Segal BH. Medical progress: Aspergillosis. N Engl J Med 2009; 360:1870–1884.
   PubMed Web of Science ®Google Scholar
• Patterson TF. Risk stratification for invasive aspergillosis: early assessment of host susceptibility. Med Mycol 2009; 47: S255–260.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical prac-tice guidelines of the infectious disease society of America. Clin Infect Dis 2008; 46: 327–360.
   PubMed Web of Science ®Google Scholar
• Verweij PE, Mellado E, Melchers WJ. Multiple-triazole-resistant aspergillosis. N Engl J Med 2007; 356:1481–1483.
   PubMed Web of Science ®Google Scholar
• Howard SJ, Arendrup MC. Aqcuired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. Med Mycol 2010; early online: 1–6.
   Google Scholar
• Snelders E, Karawajczyk A, Schaftrenaar G, Verweij PE, Melchers WJ. Azole resis-tance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling. Antimicrob Agents Chemother 2010; 54: 2425–2430.
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus am photericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347:408–415.
   PubMed Web of Science ®Google Scholar
• Pasqual A, Calandra T, Bolay S. Buclin T, Bille J, Marchetti O. Voriconazole thera-peutic drug monitoring in patients with invasive mycosis improves efficacy and safety outcomes. Clin Infect Dis 2008; 46:201–211.
   Web of Science ®Google Scholar
• Miyakis S, Van Hal SJ, Marriott D. Voriconazole concentrations and outcome of invasive fungal infections. Clin Microbiol Infect 2010; 16: 927–933.
   PubMed Web of Science ®Google Scholar
• Smith J, Safdar N, Knasinski V, Bhavnani SM, Ambrose PG, Andes D. Voricon-azole Therapeutic Drug Monitoring. Antimicrob Agents Chemother 2006; 50: 1570–1572.
   PubMed Web of Science ®Google Scholar
• Da Silva Ferreira ME, Colombo AL, Paulsen I, et al. The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Apsergillus fumigatus. Med Mycol 2005; 43: 5313–319.
   Web of Science ®Google Scholar
• Mellado E, Alcazar-Fuoli L, Garcia-Effron G, Alastruey-Izquerido A, Cuenca-Estrella M, Rodriguez-Tudela JL. New resistance mechanisms to azole drugs in Aspergillus fumigatus and emergence of antifungal drugs-resistant A. fumigatus atypical strains. Med Mycol 2006:44; 5367–371.
   Web of Science ®Google Scholar
• Blueid A, Howard SJ, Moore CB, et al. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. J Antimicrob Chemother 2010; 65:2116–2118.
   Web of Science ®Google Scholar
• Snelders E, Van der Lee HA, Kuijpers J. etal. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. Plos Med 2008:5; e219.
   PubMed Web of Science ®Google Scholar
• Howard SJ, Cerar D, Anderson MJ, et al. Frequency and evolution of azole resis-tance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 2009; 15: 1068–1076.
   PubMed Web of Science ®Google Scholar
• Verweij PE, Snelders E, Kema GH, Mellado E, Melchers WJ. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis 2009; 9: 789–795.
   PubMed Web of Science ®Google Scholar
• Snelders E, Huis in’tVeld RA, et al. Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles. Appl Environ Microbiol 2009; 75: 4053–4057.
   PubMed Web of Science ®Google Scholar
• Van der Linden J, Warns A, Van der Meer J, Bresters D, Melchers WJ, Verweij PE. Azoolresistente invasieve aspergillose. Ned Tijdschr Geneeskd 2009; 153: 1–7.
   Google Scholar
• Lagrou K, De Vleeschouwer J, Meersseman W, et al. Triazole resistance among clinical Aspergillus fumigatus isolates.3^rd Advances Against Aspergillosis, Florida, 2008.
   Google Scholar
• Maertens J, Raad I, Petrikkos G, et al. Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifunga I Therapy. Clin Infect Dis 2004; 39: 1563–1571.
   PubMed Web of Science ®Google Scholar